ARTICLE | Clinical News
Aggrastat tirofiban regulatory update
August 17, 2015 7:00 AM UTC
Cardiome submitted an sNDS to Health Canada for Aggrastat tirofiban to reduce major cardiovascular events in patients with acute myocardial infarction (AMI) intended for primary percutaneous coronary ...